scholarly article | Q13442814 |
P50 | author | Mette M. Rosenkilde | Q55097939 |
Line Barington | Q56581209 | ||
Michael Lückmann | Q57051189 | ||
Stefanie Karlshøj | Q63713705 | ||
Olav Larsen | Q87262557 | ||
Viktorija Daugvilaite | Q42323393 | ||
P2093 | author name string | Anders H Johnsen | |
Heidi Pihl | |||
Pia C Rummel | |||
Thomas M Frimurer | |||
P2860 | cites work | Sequence logos: a new way to display consensus sequences | Q24598387 |
Identification of human CCR8 as a CCL18 receptor | Q24618546 | ||
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists | Q24619974 | ||
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist | Q24654563 | ||
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor | Q24657484 | ||
Crystal structure of rhodopsin: A G protein-coupled receptor | Q27625972 | ||
Structure of a beta1-adrenergic G-protein-coupled receptor | Q27651011 | ||
Structure of the chemokine receptor CXCR1 in phospholipid bilayers | Q27674645 | ||
Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex | Q27679932 | ||
The minor binding pocket: a major player in 7TM receptor activation | Q42876628 | ||
Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction | Q44987558 | ||
Complete mutagenesis of the extracellular domain of interleukin-8 (IL-8) type A receptor identifies charged residues mediating IL-8 binding and signal transduction | Q46158410 | ||
Functional characterization of a series of mutant G protein alphaq subunits displaying promiscuous receptor coupling properties | Q47891368 | ||
Extracellular disulfide bridges serve different purposes in two homologous chemokine receptors, CCR1 and CCR5. | Q50909104 | ||
Oxazolidinones as novel human CCR8 antagonists. | Q51800103 | ||
CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes. | Q51977937 | ||
Hepatitis E vaccine debuts. | Q53354672 | ||
Allosteric Modulation of G Protein–Coupled Receptors | Q56115675 | ||
Modulation in Selectivity and Allosteric Properties of Small-Molecule Ligands for CC-Chemokine Receptors | Q56987455 | ||
Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands | Q57838214 | ||
Homology modeling with internal coordinate mechanics: deformation zone mapping and improvements of models via conformational search | Q74252568 | ||
Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28 | Q77779509 | ||
Activation of the CXCR3 chemokine receptor through anchoring of a small molecule chelator ligand between TM-III, -IV, and -VI | Q79434355 | ||
Molecular interaction of a potent nonpeptide agonist with the chemokine receptor CCR8 | Q80672149 | ||
Positive versus negative modulation of different endogenous chemokines for CC-chemokine receptor 1 by small molecule agonists through allosteric versus orthosteric binding | Q81468834 | ||
Is there a role for CCR8 in the pathogenesis of asthma? | Q84585098 | ||
Structure of the human P2Y12 receptor in complex with an antithrombotic drug | Q27682517 | ||
A general method applicable to the search for similarities in the amino acid sequence of two proteins | Q27860563 | ||
WebLogo: A Sequence Logo Generator | Q27860646 | ||
A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 | ||
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction | Q27860958 | ||
A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum | Q28114992 | ||
Mutating the four extracellular cysteines in the chemokine receptor CCR6 reveals their differing roles in receptor trafficking, ligand binding, and signaling | Q28118897 | ||
Chemokines and disease | Q28200068 | ||
GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function | Q28254935 | ||
Chemokine: receptor structure, interactions, and antagonism | Q28287562 | ||
Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor | Q28297700 | ||
Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine | Q28910426 | ||
ICM?A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation | Q29010774 | ||
Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation | Q30522852 | ||
Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28. | Q31494239 | ||
Small molecule antagonists of CCR8 inhibit eosinophil and T cell migration | Q33856688 | ||
Two disparate ligand-binding sites in the human P2Y1 receptor | Q34469331 | ||
New therapeutics that modulate chemokine networks | Q34743328 | ||
Interaction of chemokines with their receptors--from initial chemokine binding to receptor activating steps | Q35209343 | ||
Structural biology. Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor | Q35652476 | ||
The chemokine system -- a major regulator of angiogenesis in health and disease | Q35962626 | ||
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics | Q36167242 | ||
Molecular requirements for inhibition of the chemokine receptor CCR8--probe-dependent allosteric interactions. | Q36419287 | ||
GluVII:06--a highly conserved and selective anchor point for non-peptide ligands in chemokine receptors | Q36570350 | ||
Chemokines and their receptors: drug targets in immunity and inflammation | Q36947059 | ||
Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog | Q37414828 | ||
Allosteric and orthosteric sites in CC chemokine receptor (CCR5), a chimeric receptor approach | Q38795713 | ||
Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity | Q38911711 | ||
Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3. | Q39030338 | ||
Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8. | Q40176902 | ||
Cysteine residues are critical for chemokine receptor CXCR2 functional properties | Q40415960 | ||
Locating ligand-binding sites in 7TM receptors by protein engineering. | Q40535098 | ||
Similar activation of signal transduction pathways by the herpesvirus-encoded chemokine receptors US28 and ORF74. | Q40537407 | ||
The probable arrangement of the helices in G protein-coupled receptors. | Q40872681 | ||
Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor | Q41428523 | ||
In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study | Q41533540 | ||
Structure-activity relationships and identification of optmized CC-chemokine receptor CCR1, 5, and 8 metal-ion chelators | Q42265535 | ||
Reversed binding of a small molecule ligand in homologous chemokine receptors - differential role of extracellular loop 2. | Q42269169 | ||
P433 | issue | 31 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 13 | |
P304 | page(s) | 16208-16220 | |
P577 | publication date | 2016-05-19 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Role of Conserved Disulfide Bridges and Aromatic Residues in Extracellular Loop 2 of Chemokine Receptor CCR8 for Chemokine and Small Molecule Binding | |
P478 | volume | 291 |
Q90401249 | Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7 |
Q61448446 | Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation |
Search more.